RANITIDINE

H₂ receptor antagonist that prevents secretion of gastric acid

Dosage Forms

Tablet

150 mg

Injection

25 mg/ml

Uses

  • Gastritis
  • Peptic ulcer disease
  • NSAID-associated ulcer
  • Reflux oesophagitis
  • Prophylaxis of stress ulceration

Dose and Duration

Gastritis and peptic ulcer disease

By mouth,

Adult: 150 mg every 12 hours or 300 mg once daily at night for 4–8 weeks in benign gastric and duodenal ulceration, up to 6 weeks in chronic episodic dyspepsia, and up to 8 weeks in NSAID-associated ulceration (in duodenal ulcer 300 mg can be given every 12 hours for 4 weeks to achieve a higher healing rate)

By IM injection,

Adult: 50 mg every 6–8 hours

By slow IV injection,

Adult: 50 mg diluted to 20 ml and given over at least 2 minutes, may be repeated every 6–8 hours

Prophylaxis of NSAID-associated gastric or duodenal ulcer

Adult: 300 mg every 12 hours until completion of NSAIDs

Prophylaxis of stress ulceration

Adult: 50 mg every 8 hours by slow IV injection over at least 2 minutes, then adjusted to 150 mg every 12 hours by mouth when oral feeding commences

Reflux oesophagitis

Adult: by mouth, 150 mg every 12 hours or 300 mg once at night for up to 8–12 weeks as necessary, increased in moderate to severe disease to 600 mg daily in 2–4 divided doses for up to 12 weeks

Long-term treatment of healed gastro-oesophageal reflux disease

150 mg every 12 hours

All uses

By mouth,

Child 12–18 years: 150 mg every 12 hours or 300 mg once at night; increased if necessary to 300 mg every 12 hours or 150 mg every 6 hours for up to 12 weeks in moderate to severe gastritis

Child 3–12 years: 2–4 mg/kg (max 150 mg) every 12 hours, increased up to 5 mg/kg (max 300 mg) every 12 hours in severe gastritis

Child 6 months–3 years: 2–4 mg/kg every 12 hours

Child 1–6 months: 1 mg/kg every 8 hours (max 3 mg/kg every 8 hours)

Neonate: 2 mg/kg every 8 hours (max 3 mg/kg every 8 hours)

By slow IV injection,

Child 1 month–18 years: 1 mg/kg (max 50 mg) every 6–8 hours (may be given as an intermittent infusion at a rate of 25 mg/hour)

Neonate: 0.5–1 mg/kg every 6–8 hours

Preparation

  • For slow IV injection dilute to a concentration of 2.5 mg/ml with glucose 5% or sodium chloride 0.9%

Contra-indications

  • Hypersensitivity
  • Porphyria

Side Effects

  • Abdominal pain, constipation, nausea, diarrhoea
  • Headache

Interactions

  • Atazanavir (reduced plasma concentration of atazanavir)

Pregnancy

  • Can be used

Breast-feeding

  • Can be used

⚠️ Caution

  • Oral absorption in neonates is not reliable
  • Use half normal dose in severe renal failure
  • Reduce dose in hepatic failure